NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain

被引:312
|
作者
Huang, BH [1 ]
Eberstadt, M [1 ]
Olejniczak, ET [1 ]
Meadows, RP [1 ]
Fesik, SW [1 ]
机构
[1] ABBOTT LABS,DIV PHARMACEUT DISCOVERY,ABBOTT PK,IL 60064
关键词
D O I
10.1038/384638a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
PROGRAMMED cell death (apoptosis) mediated by the cytokine receptor Fas is critical for the removal of autoreactive T cells(1), the mechanism of immune privilege(2,3), and for maintenance of immune-system homeostasis(4). Signalling of programmed cell death involves the self-association of a conserved cytoplasmic region of Fas called the death domain(5-7) and interaction with another death-domain-containing protein, FADD(8) (also known as MORT1)(9). Although death domains are found in several proteins(10), their three dimensional structure and the manner in which they interact is unknown, Here we describe the solution structure of the Fas death domain, as determined by NMR spectroscopy, The structure consists of six antiparallel, amphipathic a-helices arranged in a novel fold, From the structure and from site-directed mutagenesis, we have identified the region of the death domain involved in self-association and binding to the downstream signalling partner FADD.
引用
收藏
页码:638 / 641
页数:4
相关论文
共 50 条
  • [31] CD95 (APO-1/FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    BARGOU, RC
    KRAMMER, P
    DORKEN, B
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 831 - 831
  • [32] RIP - A NOVEL PROTEIN CONTAINING A DEATH DOMAIN THAT INTERACTS WITH FAS/APO-1 (CD95) IN YEAST AND CAUSES CELL-DEATH
    STANGER, BZ
    LEDER, P
    LEE, TH
    KIM, E
    SEED, B
    CELL, 1995, 81 (04) : 513 - 523
  • [33] FAS (APO-1 CD95) ACTIVATION INDUCES APOPTOSIS IN HUMAN PHAGOCYTES
    LILES, WC
    DALE, DC
    KLEBANOFF, SJ
    BLOOD, 1994, 84 (10) : A371 - A371
  • [34] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    D Bouscary
    J De Vos
    M Guesnu
    K Jondeau
    F Viguier
    J Melle
    F Picard
    F Dreyfus
    M Fontenay-Roupie
    Leukemia, 1997, 11 : 839 - 845
  • [35] Drug-induced CD95 (APO-1/FAS)-mediated apoptosis
    Krammer, PH
    ANNALS OF ONCOLOGY, 1998, 9 : 13 - 13
  • [36] Disturbances of the CD95 (APO-1/Fas) system in disorders of lymphohaematopoietic cells
    Debatin, KM
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 185 - 189
  • [37] Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway
    Becker, K
    Schneider, P
    Hofmann, K
    Mattmann, C
    Tschopp, J
    FEBS LETTERS, 1997, 412 (01) : 102 - 106
  • [38] Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
    Shin, MS
    Park, WS
    Kim, SY
    Kim, HS
    Kang, SJ
    Song, KY
    Park, JY
    Dong, SM
    Pi, JH
    Oh, RR
    Lee, JY
    Yoo, NJ
    Lee, SH
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06): : 1785 - 1791
  • [39] Protein kinase C regulates Fas (CD95/APO-1) expression
    Wang, RX
    Zhang, LY
    Yin, DL
    Mufson, A
    Shi, YF
    JOURNAL OF IMMUNOLOGY, 1998, 161 (05): : 2201 - 2207
  • [40] Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
    Lee, SH
    Shin, MS
    Park, WS
    Lee, JY
    Yoo, NJ
    JOURNAL OF PATHOLOGY, 1999, 189 : 27A - 27A